Mesoporous bioactive glass scaffolds for efficient delivery of vascular endothelial growth factor

Journal of Biomaterials Applications

Volumn 28, Issue 3, 2013, Pages 367-374

  Wu, Chengtie ^a   Fan, Wei ^b   Chang, Jiang ^a   Xiao, Yin ^b,c  

^a SHANGHAI INSTITUTE OF CERAMICS   (China)

^b Wuhan University   (China)

^c QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

Author keywords

Mesoporous bioactive glass; scaffolds; tissue engineering; vascular endothelial growth factor delivery

Indexed keywords

BONE TISSUE ENGINEERING; BURST RELEASE; LOADING EFFICIENCY; MESOPORE STRUCTURES; MESOPOROUS BIOACTIVE GLASS; SUSTAINED RELEASE; VASCULAR ENDOTHELIAL GROWTH FACTOR;

BIOACTIVE GLASS; ENDOTHELIAL CELLS; MESOPOROUS MATERIALS; SCAFFOLDS; TISSUE ENGINEERING;

SCAFFOLDS (BIOLOGY);

MESOPOROUS BIOACTIVE GLASS SCAFFOLD; TISSUE SCAFFOLD; UNCLASSIFIED DRUG; VASCULOTROPIN;

ARTICLE; CELL VIABILITY; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; HUMAN; HUMAN CELL; SCANNING ELECTRON MICROSCOPY; SUSTAINED DRUG RELEASE; TISSUE ENGINEERING; TRANSMISSION ELECTRON MICROSCOPY; UMBILICAL VEIN ENDOTHELIAL CELL;

MESOPOROUS BIOACTIVE GLASS; SCAFFOLDS; TISSUE ENGINEERING; VASCULAR ENDOTHELIAL GROWTH FACTOR DELIVERY;

DRUG DELIVERY SYSTEMS; GLASS; MICROSCOPY, ELECTRON, SCANNING; TISSUE SCAFFOLDS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84883416940     PISSN: 08853282     EISSN: 15308022     Source Type: Journal    
DOI: 10.1177/0885328212453635     Document Type: Article

References (31)

1. Langer R, Vacanti JP. Tissue engineering. Science. 1993 ; 260 (5110). 920-926
2. Wu C, Chang J, Zhai W, et al. Porous akermanite scaffolds for bone tissue engineering: preparation, characterization, and in vitro studies. J Biomed Mater Res B Appl Biomater. 2006 ; 78 (1). 47-55
3. Hausman MR, Schaffler MB, Majeska RJ. Prevention of fracture healing in rats by an inhibitor of angiogenesis. Bone. 2001 ; 29 (6). 560-564
4. Ferrara N, Davis-Smyth T. The biology of vascular endothelial growth factor. Endocr Rev. 1997 ; 18 (1). 4-25
5. Lode A, Wolf-Brandstetter C, Reinstorf A, et al. Calcium phosphate bone cements, functionalized with VEGF: release kinetics and biological activity. J Biomed Mater Res A. 2007 ; 81 (2). 474-483
6. Soker S, Machado M, Atala A. Systems for therapeutic angiogenesis in tissue engineering. World J Urol. 2000 ; 18 (1). 10-18
7. Lee KY, Peters MC, Mooney DJ. Comparison of vascular endothelial growth factor and basic fibroblast growth factor on angiogenesis in SCID mice. J Control Release. 2003 ; 87 (1-3). 49-56
8. Briganti E, Spiller D, Mirtelli C, et al. A composite fibrin-based scaffold for controlled delivery of bioactive pro-angiogenetic growth factors. J Control Release. 2010 ; 142 (1). 14-21
9. Naderi H, Matin MM, Bahrami AR. Review paper: critical issues in tissue engineering: biomaterials, cell sources, angiogenesis, and drug delivery systems. J Biomater Appl. 2011 ; 26 (4). 383-417
10. Jay SM, Saltzman WM. Controlled delivery of VEGF via modulation of alginate microparticle ionic crosslinking. J Control Release. 2009 ; 134 (1). 26-34
11. Karal-Yilmaz O, Serhatli M, Baysal K, et al. Preparation and in vitro characterization of vascular endothelial growth factor (VEGF)-loaded poly(D,L-lactic-co-glycolic acid) microspheres using a double emulsion/solvent evaporation technique. J Microencapsul. 2011 ; 28 (1). 46-54
12. Formiga FR, Pelacho B, Garbayo E, et al. Sustained release of VEGF through PLGA microparticles improves vasculogenesis and tissue remodeling in an acute myocardial ischemia-reperfusion model. J Control Release. 2010 ; 147 (1). 30-37
13. Lee JS, Wagoner Johnson AJ, Murphy WL. A modular, hydroxyapatite-binding version of vascular endothelial growth factor. Adv Mater. 2010 ; 22 (48). 5494-5498
14. Vallet-Regi M. Ordered mesoporous materials in the context of drug delivery systems and bone tissue engineering. Chem Eur J. 2006 ; 12 (23). 5934-5943
15. Vallet-Regi M, Balas F, Arcos D. Mesoporous materials for drug delivery. Angew Chem Int Ed Engl. 2007 ; 46 (40). 7548-7558
16. Yan X, Huang X, Yu C, et al. The in vitro bioactivity of mesoporous bioactive glasses. Biomaterials. 2006 ; 27 (18). 3396-3403
17. Gao Y, Chang J. Surface modification of bioactive glasses and preparation of PDLLA/bioactive glass composite films. J Biomater Appl. 2009 ; 24 (2). 119-138
18. Wu C, Zhang Y, Zhu Y, et al. Structure-property relationships of silk-modified mesoporous bioglass scaffolds. Biomaterials. 2010 ; 31 (13). 3429-3438
19. Wu C, Zhou Y, Fan W, et al. Hypoxia-mimicking mesoporous bioactive glass scaffolds with controllable cobalt ion release for bone tissue engineering. Biomaterials. 2012 ; 33 (7). 2076-2085
20. Wu C, Ramaswamy Y, Zhu Y, et al. The effect of mesoporous bioactive glass on the physiochemical, biological and drug-release properties of poly(DL-lactide-co- glycolide) films. Biomaterials. 2009 ; 30 (12). 2199-2208
21. Wu C, Zhang Y, Zhou Y, et al. A comparative study of mesoporous-glass/ silk and non-mesoporous-glass/silk scaffolds: physiochemistry and in vivo osteogenesis. Acta Biomater. 2011 ; 7 (5). 2229-2236
22. Gorustovich AA, Roether JA, Boccaccini AR. Effect of bioactive glasses on angiogenesis: a review of in vitro and in vivo evidences. Tissue Eng Part B Rev. 16 (2). 199-207
23. Wu C, Fan W, Zhu Y, et al. Magnetic mesoporous bioactive glass scaffolds with hierarchical pore structure and multifunction. Acta Biomater. 2011 ; 7 (10). 3563-3572
24. Wu C, Miron R, Sculeaan A, et al. Proliferation, differentiation and gene expression of osteoblasts in boron-containing associated with dexamethasone deliver from mesoporous bioactive glass scaffolds. Biomaterials. 2011 ; 32 (29). 7068-7078
25. Tigli RS, Akman AC, Gumusderelioglu M, et al. In vitro release of dexamethasone or bFGF from chitosan/hydroxyapatite scaffolds. J Biomater Sci Polym Ed. 2009 ; 20 (13). 1899-1914
26. Xia W, Chang J. Well-ordered mesoporous bioactive glasses (MBG): a promising bioactive drug delivery system. J Control Release. 2006 ; 110 (3). 522-530
27. Zhu YF, Kaskel S. Comparison of the in vitro bioactivity and drug release property of mesoporous bioactive glasses (MBGs) and bioactive glasses (BGs) scaffolds. Micropor Mesopor Mater. 2009 ; 118 (1-3). 176-182
28. Vallet-Regi M, Ramila A, del Real RP, et al. A new property of MCM-41: drug delivery system. Chem Mater. 2001 ; 13 (2). 308-311
29. Doadrio AL, Sousa EM, Doadrio JC, et al. Mesoporous SBA-15 HPLC evaluation for controlled gentamicin drug delivery. J Control Release. 2004 ; 97 (1). 125-132
30. Vallet-Regi M, Doadrio J, Doadrio A, et al. Hexagonal ordered mesoporous materials as a matrix for the controlled release of amoxicillin. Solid State Ionics. 2004 ; 172 (1-4). 435-439
31. Wu C, Zhang Y, Ke X, et al. Bioactive mesopore-glass microspheres with controllable protein-delivery properties by biomimetic surface modification. J Biomed Mater Res A. 2010 ; 95 (2). 476-485